Literature DB >> 7561925

Non-progressive familial idiopathic intracranial calcification: a family report.

J S Callender1.   

Abstract

The clinical features and long term outcome of familial idiopathic intracranial calcification in three members of one family are described. The illness presented as psychiatric disorder in all patients, and in one patient, epilepsy and intellectual deterioration were later manifestations. Skull radiographs and CT were performed sequentially, in one patient, over a 22 year period and, in another, CT was carried out eight years apart. In neither patient was there any evidence of progression of calcification.

Entities:  

Mesh:

Year:  1995        PMID: 7561925      PMCID: PMC486082          DOI: 10.1136/jnnp.59.4.432

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  5 in total

1.  Basal ganglia role in behavior: importance of sensory gating and its relevance to psychiatry.

Authors:  J S Schneider
Journal:  Biol Psychiatry       Date:  1984-12       Impact factor: 13.382

2.  No difference in basal ganglia mineralization between schizophrenic and nonschizophrenic patients: a quantitative computerized tomographic study.

Authors:  M F Casanova; C M Prasad; I Waldman; B Illowsky; B Stein; D R Weinberger; J B Kleinman
Journal:  Biol Psychiatry       Date:  1990-01-15       Impact factor: 13.382

3.  The significance of the incidental finding of basal ganglia calcification on computed tomography.

Authors:  M G Harrington; P Macpherson; W B McIntosh; B F Allam; I Bone
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-12       Impact factor: 10.154

4.  Bilateral basal ganglia calcifications visualised on CT scan.

Authors:  T S Brannan; A A Burger; M Y Chaudhary
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-05       Impact factor: 10.154

Review 5.  Familial calcification of the basal ganglia: a case report and review of the literature.

Authors:  J Flint; L H Goldstein
Journal:  Psychol Med       Date:  1992-08       Impact factor: 7.723

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.